Cargando…
Survival in non-small cell lung cancer patients with versus without prior cancer
Clinical trials on cancer treatments frequently exclude patients with prior cancer, but more evidence is needed to understand their possible effects on outcomes. This study analyzed the prognostic impact of prior cancer in newly diagnosed non-small cell lung cancer (NSCLC) patients while accounting...
Autores principales: | Sato, Akira, Morishima, Toshitaka, Takeuchi, Masato, Nakata, Kayo, Kawakami, Koji, Miyashiro, Isao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017802/ https://www.ncbi.nlm.nih.gov/pubmed/36922574 http://dx.doi.org/10.1038/s41598-023-30850-2 |
Ejemplares similares
-
Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study
por: Sato, Akira, et al.
Publicado: (2021) -
Geriatric assessment domains to predict overall survival in older cancer patients: An analysis of functional status, comorbidities, and nutritional status as prognostic factors
por: Morishima, Toshitaka, et al.
Publicado: (2020) -
Between-hospital variations in 3-year survival among patients with newly diagnosed gastric, colorectal, and lung cancer
por: Morishima, Toshitaka, et al.
Publicado: (2022) -
Minimum surgical volume to ensure 5‐year survival probability for six cancer sites in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2022) -
Surgical volume threshold to improve 3‐year survival in designated cancer care hospitals in 2004‐2012 in Japan
por: Okawa, Sumiyo, et al.
Publicado: (2022)